SUBSCRIBE
SUBSCRIBE

Roche

NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Struggling Eleven Bio Forges Deal Worth $270 Million with Pharma Giant Roche
June 13, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Rumors Floating Again that Roche or GlaxoSmithKline Might Acquire Bay Area’s Pacific Biosciences
June 3, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Roche and Novartis AG Gear Up to Battle Over Biosimilars
May 31, 2016
 · 
3 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Deals
Amid Restructuring and Lawsuits, Novartis AG Indicates It Might Sell $14 Billion Roche Stock Without a Premium
May 25, 2016
 · 
2 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Deals
Novartis AG Mulls Over Selling $14 Billion Roche Stake to Potentially Free Up Cash for New Deals
April 25, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Backed by Pfizer and Roche, Bay Area’s Second Genome Nabs $42.6 Million
April 20, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Pharm Country
Johnson & Johnson and Roche Could Be the Storm Off Celgene’s Horizon
March 24, 2016
 · 
3 min read
Biotech Bay
The 8 Best Pharmaceutical Companies to Work for
Looking for the best pharmaceutical companies to work for? Here’s the list of the top 8 pharma companies that are hiring right now. So, let’s check the list.
March 16, 2016
 · 
8 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG’s Leukemia Drug Gets Breakthrough Designation, Same Week as AstraZeneca PLC and Roche Drugs
February 19, 2016
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Roche receives CE mark for new blood test to detect Alzheimer’s pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
May 12, 2026
 · 
10 min read
Press Releases
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
May 7, 2026
 · 
4 min read
Press Releases
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026
 · 
15 min read
Press Releases
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
April 30, 2026
 · 
11 min read
Press Releases
Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management
April 29, 2026
 · 
6 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
April 23, 2026
 · 
20 min read
Press Releases
Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
April 22, 2026
 · 
15 min read
Press Releases
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
April 22, 2026
 · 
10 min read
Press Releases
Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD
April 22, 2026
 · 
12 min read
Press Releases
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
April 21, 2026
 · 
9 min read
Load More